FOXILAT Trademark

Trademark Overview

On Monday, January 24, 2011, a trademark application was filed for FOXILAT with the United States Patent and Trademark Office. The USPTO has given the FOXILAT trademark a serial number of 85224186. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 1, 2014. This trademark is owned by Glaxo Group Limited. The FOXILAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
foxilat

General Information

Serial Number85224186
Word MarkFOXILAT
Filing DateMonday, January 24, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 27, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, September 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 25, 2014EXTENSION 5 GRANTED
Wednesday, January 22, 2014EXTENSION 5 FILED
Wednesday, January 22, 2014TEAS EXTENSION RECEIVED
Wednesday, July 24, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2013EXTENSION 4 GRANTED
Friday, July 19, 2013EXTENSION 4 FILED
Friday, July 19, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 22, 2013EXTENSION 3 GRANTED
Sunday, January 20, 2013EXTENSION 3 FILED
Sunday, January 20, 2013TEAS EXTENSION RECEIVED
Thursday, August 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2012EXTENSION 2 GRANTED
Friday, July 20, 2012EXTENSION 2 FILED
Wednesday, August 8, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 20, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2011PUBLISHED FOR OPPOSITION
Thursday, April 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 14, 2011ASSIGNED TO EXAMINER
Thursday, January 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 27, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

foxilat pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological